Sight Sciences, Inc. (SGHT) analyst actions
Rating and price-target actions on SGHT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SGHT overview →
4 measured SGHT analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance | Press release | -8.65% | -17.50% | |
| Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance | Press release | +2.22% | +10.67% | |
| Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial | Press release | -0.49% | -5.68% | |
| Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance | Press release | +6.52% | +1.03% |
Keep exploring
More SGHT: earnings → · SEC filings → · SGHT overview →